Mereo BioPharma (MREO) Interest Expenses (2023 - 2026)

Mereo BioPharma (MREO) has 4 years of Interest Expenses data on file, last reported at $206000.0 in Q1 2026.

• On a quarterly basis, Interest Expenses rose 7.29% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was $1.8 million, a 54.83% decrease from a year earlier, with the FY2025 full-year figure at $226.8 million, up 16452.04% from the prior year.
• Interest Expenses for Q1 2026 stood at $206000.0, up from $23000.0 in the prior quarter.
• Over the last five years, Interest Expenses for MREO reached as high as $10.1 million in Q2 2025 and fell as low as $23000.0 in Q4 2025.
• Historically, Interest Expenses has averaged $1.8 million across 4 years, with a median of $800000.0 in 2023.
• Across the five-year window, Interest Expenses jumped 337.0% in 2024 and slumped 98.31% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $2.1 million in 2023, then tumbled by 34.65% to $1.4 million in 2024, then slumped by 98.31% to $23000.0 in 2025, then soared by 795.65% to $206000.0 in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $206000.0 in Q1 2026, $23000.0 in Q4 2025, and $704000.0 in Q3 2025.